Cholangiocarcinoma

Precision Medicine and Real-World Clinical Insights
Discover our exclusive three-part e-learning series on cholangiocarcinoma. Throughout these sessions our experts guide you through the evolving role of molecular testing, targeted therapies and practical patient management for IDH1-mutant cholangiocarcinoma, with a focus on real-world Belgian clinical practice.
  • Session 1: Diagnosis, molecular profiling, and first-line treatment strategies.  -Now Available-
  • Session 2: Deep dive into the ClarIDHy trial and the use of ivosidenib.  -Available from 21 May-
  • Session 3: Practical case discussions, safety management, and treatment decision-making.  -Available from 28 May-

Expert panel:

Prof Anne Demols
Prof Karen Geboes
Prof Jeroen Dekervel

Cholangiocarcinoma

Precision Medicine and Real-World Clinical Insights
Discover our exclusive three-part e-learning series on cholangiocarcinoma, presented by leading experts Prof Jeroen Dekervel (UZ Leuven), Prof Anne Demols (HUB Brussels) and Prof Karen Geboes (UZ Gent). Throughout these sessions, they guide you through the evolving role of molecular testing, targeted therapies, and practical patient management for IDH1-mutant cholangiocarcinoma, with a focus on real-world Belgian clinical practice.
  • Session 1: Diagnosis, molecular profiling, and first-line treatment strategies.
  • Session 2: Deep dive into the ClarIDHy trial and the use of ivosidenib.
  • Session 3: Practical case discussions, safety management, and treatment decision-making.

Register to access the full videos and earn accreditation points.

* This educational content is intended for healthcare professionals and is made possible with the educational support of Servier.

This course is currently available for physicians only.